67 results
8-K/A
EX-10.1
CHRS
Coherus Biosciences Inc
21 May 24
Financial Statements and Exhibits
5:14pm
or any actual or alleged Hazardous Materials Activity; or (iii) in connection with any actual or alleged damage, injury, threat or harm to health, safety
8-K
EX-2.1
CHRS
Coherus Biosciences Inc
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
Knowledge threatened, (i) relating to any injury to person or property or as a result of ownership, possession, provision or use of the Product or (ii … of any injury as a result of the use of the Product.
(d) During the last three years, there have been no material recalls, field notifications, field
8-K
CHRS
Coherus Biosciences Inc
26 Dec 23
Other Events
8:49pm
and well-tolerated adhesive. After the dose is administered, the needle automatically retracts, which reduces the risk of needlestick injury.
The approval
424B3
svu9b08wr48mf9fp6
26 Jul 23
Prospectus supplement
4:59pm
S-4/A
5k5lsz8qc1qh
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
S-4
51ecapj0phk
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
425
0tiz2xyq zpd
16 Jun 23
Business combination disclosure
8:08am
425
9rsja
16 Jun 23
Business combination disclosure
7:09am
8-K
EX-2.1
l0r 9zdfmux7q3x
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
8-K
EX-10.1
fo0vs0f pg
7 Jan 22
Coherus BioSciences Secures Credit Financing
8:36am